|
|
|
| home > white papers > Overcoming research challenges with Adaptive Trials - PCI Pharma Services |
|
|
 WHITE PAPERS |
|
PCI Pharma Services
|
|
Overcoming research challenges with Adaptive Trials
|
|
There has been cause for concern within the pharmaceutical industry over
the last five years, regarding increasing research and development
costs, combined with a fall in the number of new drugs brought to
market. In an attempt to overcome this issue there has been a
significant rise in the use of adaptive clinical trial designs, whilst
saving time and money as well as facilitating more effective decision
making. One of the biggest challenges that pharmaceutical companies have
experienced has been delivering compliant clinical trials supplies
across diverse patient populations in the relatively short timeframes
that adaptive trial designs require, remaining focused on ensuring that
patient compliance and product quality is in no way compromised. This
demand has led to the launch of fast response services that support
Research and Development in responding to changing dosing regimens
mid-trial.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio
BioIVT,
a leading provider of research models and services for drug development, today
announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and
its comprehensive portfolio of transporter assays, multi-transporter models,
transporter systems biology, and molecular transport research solutions.
More info >> |
|
 |
White Papers |
 |
|
Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?
Clinical Professionals
Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >> |
|
 |
Industry Events |
 |
Synthetic Biology Congress
8-9 November 2018, London, UK
Oxford Global is proud to present its Synthetic
Biology Congress taking place on 8-9 November 2018 in London. As
part of our Genomics and Synthetic Biology UK series, our congress will
bring together Over 600 delegates representing internationally renowned
research & academic institutions, clinical research institutions and
pharmaceutical companies.
More info >> |
|
|
|
